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Appraisal Clinimetrics
The Depression Anxiety Stress Scale (DASS)
Description
The DASS is a 42-item self-administered questionnaire 
designed to measure the magnitude of three negative 
emotional states: depression, anxiety, and stress. The DASS-
Depression focuses on reports of low mood, motivation, 
and self-esteem, DASS-anxiety on physiological arousal, 
perceived panic, and fear, and DASS-stress on tension and 
irritability.
Instructions to client and scoring: A respondent indicates 
on a 4-point scale the extent to which each of 42 statements 
applied over the past week. A printed overlay is used to 
obtain total scores for each subscale. Higher scores on each 
subscale indicate increasing severity of depression, anxiety, 
or stress. Completion takes 10 to 20 minutes. A shorter, 
21-item version of the DASS (DASS-21), which takes 5 to 
10 minutes to complete, is also available. Subscale scores 
from the shorter questionnaire are converted to the DASS 
normative data by multiplying the total scores by 2.
Individual patient scores on the DASS subscales can be 
interpreted by converting them to z-scores and comparing 
to the normative values contained within the DASS manual. 
A z-score  0.5 is considered to be within the normal range, 
a z-score of 0.5 to 1.0 is mild, 1.0 to 2.0 is moderate, 2.0 to 
3.0 is considered severe, and z-scores ® 3 are considered to 
be extremely severe depression/anxiety/stress. Although it 
has been suggested that a composite measure of negative 
mood can be obtained by taking a mean of the 3 subscales, 
interpretation of this score is problematic as normative data 
or cut-off scores are not currently available.
Clinimetrics: Internal consistency for each of the subscales 
of the 42-item and the 21-item versions of the questionnaire 
are typically high (eg Cronbach’s α of 0.96 to 0.97 for DASS-
Depression, 0.84 to 0.92 for DASS-Anxiety, and 0.90 to 0.95 
for DASS-Stress (Lovibond 1995, Brown et al 1997, Antony 
et al 1998, Clara 2001, Page 2007). There is good evidence 
that the scales are stable over time (Brown et al 1997) and 
responsive to treatment directed at mood problems (Ng 
2007). Evidence has been found for construct (Lovibond 
1995) and convergent (Crawford and Henry 2003) validity 
for the anxiety and depression subscales of both the long 
and short versions of the DASS. The clinimetric properties 
of the questionnaire have been examined in general and 
clinical populations Including chronic pain (Taylor 2005), 
post myocardial infarction (Lovibond 1995), psychiatric in-
patients (Ng 2007) and out-patients (Lovibond 1995).
Commentary
Patients who present for physiotherapy care may also have 
low or disturbed mood, particularly clinically relevant 
symptoms of depression and anxiety. Co-morbid mood 
disturbance is likely to inﬂuence patients’ symptoms 
(including reporting of symptoms), complicate management, 
and slow recovery from the primary presenting condition. 
Accurate evaluation of mood is therefore an essential 
element of a comprehensive physiotherapy assessment. The 
application of a valid questionnaire is likely to assist with 
evaluating mood disturbance and will reduce the likelihood 
of the clinician failing to recognise these problems 
(Haggman 2004).
A variety of questionnaires assess mood disturbance but 
many contain somatic items (eg sleep problems, loss of 
appetite), which are likely to reﬂect the patient’s presenting 
condition rather than any mood disturbance. The DASS 
was developed with somatic items excluded to address 
this problem speciﬁcally. It is therefore likely to provide 
clinicians with an accurate assessment of their patient’s 
symptoms of depression, anxiety and stress.
The DASS has excellent clinimetric properties and few 
limitations, however clinicians should be aware that 
certain patient groups (eg children, the developmentally 
delayed, or those who are taking certain medications) may 
have difﬁculty understanding the questionnaire items or 
responding to them in an unbiased manner. For non-English 
speaking patients over 25 translations of the DASS are 
available.
Finally, we caution against using the DASS scores to 
independently diagnose discrete mood disorders such as 
depression. The DASS is not intended to replace a complete 
psychological assessment. It is important to remember that 
DASS severity ratings are based on mean population scores 
obtained from large, relatively heterogenous samples. On 
this basis, an individual severity rating reﬂects how far 
scores are positioned from these population means; the 
further away the score is from the population mean, the 
more severe the symptoms. If DASS scores suggest that a 
patient has signiﬁcant symptoms of depression, anxiety, or 
stress, then referral to a qualiﬁed colleague with experience 
in managing mood disturbance is required.
For more information on the DASS the developers have 
provided a comprehensive FA  section on their web 
page, along with an overview and link to download the 
questionnaire.
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